Skip to main content
Clinical Trials/ITMCTR2200006375
ITMCTR2200006375
Not yet recruiting
未知

Clinical study of wet age-related macular degeneration with Traditional Chinese medicine and Western medicine

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Shanghai Eye Disease Prevention and Treatment Center
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Any one eye meets the western diagnostic criteria of wet AMD;
  • 2\) Age \=50;
  • 3\) Intravitreal injection of anti\-VEGF drugs is required
  • 4\) The refractive stroma is basically clear, fundus examination and fundus OCTA are feasible;
  • 5\) Patients had good compliance with the observation and efficacy evaluation of the study and signed informed consent.

Exclusion Criteria

  • 1\) The refractive medium is not clear enough to conduct fundus observer.
  • 2\) Combined with glaucoma, uveitis, severe cataract, vitreous hematocele, fundus vein obstruction, optic neuritis, retinal detachment and other ophthalmic diseases affecting vision or effect observation.
  • 3\) Patients who have received fundus surgery and laser treatment
  • 4\) Patients who had received intravitreal drug injection in last 3 months
  • 5\) complicated with other organs (such as heart, brain, liver) and other serious diseases, or mental patients.
  • 6\) Women who are pregnant, trying to become pregnant or breastfeeding.
  • 7\) Severe allergy to fluorescein sodium and indocyanqing green needles.

Outcomes

Primary Outcomes

Not specified

Similar Trials